References
- 1. Hoeper MM, Bogaard HJ, Condliffe R, et al. Definitions and diagnosis of pulmonary hypertension. J Am Coll Cardiol. 2013;62(Suppl):D42-D50.10.1016/j.jacc.2013.10.03224355641
- 2. Nader Kamangar et al, Secondary Pulmonary Hypertension, http://emedicine.medscape.com/article/303098-overview#showall
- 3. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. European Heart Journal. 2016;37,67-119. doi:10.1093/eurheartj/ehv317.10.1093/eurheartj/ehv31726320113
- 4. Khanna D, Gladue H, Channick R, et al. Recommendations for screening and detection of connective tissue disease-associated pulmonary arterial hypertension. Arthritis Rheum. 2013;65:3194-3201.10.1002/art.38172388357124022584
- 5. Hajj-ali, RA (June 2013). Systemic Sclerosis. Merck Manual Professional. Merck Sharp & Dohme Corp.
- 6. Vandecasteele EH, De Pauw M, Brusselle G, et al. The heart and pulmonary arterial hypertension in systemic sclerosis. Acta Clin Belg. 2016;5:1-18.10.1080/17843286.2015.110853827075793
- 7. Hachulla E, Gressin V, Guillevin L, et al. Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study. Arthritis Rheum. 2005;52:3792-3800.10.1002/art.2143316320330
- 8. Clements PJ, Tan M, McLaughlin VV, et al. The pulmonary arterial hypertension quality enhancement research initiative: comparison of patients with idiopathic PAH to patients with systemic sclerosis-associated PAH. Ann Rheum Dis. 2012;71:249-252.10.1136/annrheumdis-2011-20026521998119
- 9. Van der Hogen, et al. 2013 ACR/EULAR Classification Criteria for Scleroderma, Arthritis and Rheumatism. 2013,65:2737-2747.
- 10. Kavanaugh A, Tomar R, Reveille J, et al. Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens. American College of Pathologists. Arch Pathol Lab Med. 2000;124:71.10.5858/2000-124-0071-GFCUOT10629135
- 11. Russo K, Hoch S, Dima C, et al. Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis. J Rheumatol. 2000;27:142.
- 12. Steen VD, Medsger TA. Changes in causes of death in systemic sclerosis, 1972–2002. Ann Rheum Dis. 2007; 66:940-944.10.1136/ard.2006.066068195511417329309
- 13. Gabrielli A, Avvedimento EV, Krieg T. Scleroderma. N Engl J Med. 2009;360:1989-2003.10.1056/NEJMra080618819420368